Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
101.12
+1.72 (1.73%)
Nov 22, 2024, 4:00 PM EST - Market closed
Encompass Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Encompass Health stock have an average target of 106.75, with a low estimate of 95 and a high estimate of 117. The average target predicts an increase of 5.57% from the current stock price of 101.12.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EHC stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 3 | 3 |
| Buy | 4 | 5 | 3 | 3 | 5 | 5 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | +8.78% | Oct 30, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $108 → $116 | Strong Buy | Reiterates | $108 → $116 | +14.72% | Oct 30, 2024 |
| Barclays | Barclays | Buy Maintains $109 → $116 | Buy | Maintains | $109 → $116 | +14.72% | Oct 29, 2024 |
| Keybanc | Keybanc | Buy Maintains $115 → $117 | Buy | Maintains | $115 → $117 | +15.70% | Oct 29, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $104 → $108 | Strong Buy | Maintains | $104 → $108 | +6.80% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
5.40B
from 4.80B
Increased by 12.51%
Revenue Next Year
5.89B
from 5.40B
Increased by 9.11%
EPS This Year
4.32
from 3.47
Increased by 24.35%
EPS Next Year
4.84
from 4.32
Increased by 11.94%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.6B | 6.3B | 6.8B |
| Avg | 5.4B | 5.9B | 6.4B |
| Low | 5.2B | 5.6B | 6.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 17.3% | 15.9% | 15.8% |
| Avg | 12.5% | 9.1% | 8.6% |
| Low | 8.8% | 4.2% | 3.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 4.58 | 5.51 | 6.35 |
| Avg | 4.32 | 4.84 | 5.35 |
| Low | 4.05 | 4.36 | 4.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 31.7% | 27.6% | 31.3% |
| Avg | 24.3% | 11.9% | 10.7% |
| Low | 16.5% | 0.9% | -3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.